| Date | Title | Description |
| 28.07.2026 | Researchers Map Vagus Nerve Fiber by Fiber to Fix Vagus Nerve Stimulation Side-Effect Problem | By Brandi Henkel
Published: Jul 28 2026, 4:03 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 17.09.2025 | Kingstec Technologies Celebrates FDA Approval of SetPoint Medical’s Revolutionary RA Treatment | SetPoint Medical Revolutionary RA Treatment
Strategic manufacturing partner’s expertise instrumental in bringing first-of-its-kind rheumatoid arthritis treatment to market MISSISSAUGA, ONTARIO, CANADA, September 17, 2025 /EINPresswire.com/ ... |
| 25.08.2025 | SetPoint Hits Market
Targeting the vagus nerve
Rheumatoid arthritis relief
Financing rounds
Next up: Multiple sclerosis? | - |
| 18.08.2025 | SetPoint Medical Bags $140M in Series C and D |
VALENCIA, CA, SetPoint has raised $140 million in private funding included $25 million in a second tranche of its Series C round and $115 million in its Series D financing.
>> Click here for more funding data on SetPoint Medical
>... |
| 15.08.2025 | Top Startup and Tech Funding News Roundup – Week Ending August 15, 2025 | It’s Friday, August 15, 2025, and we’re back with the top startup and tech funding stories that shaped the week. From billion-dollar debt financings and nine-figure biotech rounds to stealth AI ventures breaking cover with ambitious plans, ... |
| 12.08.2025 | SetPoint Medical Secures $140M for Groundbreaking RA Therapy | SetPoint Medical gained $140M in new funding for its innovative neuroimmune modulation therapy. The FDA-approved SetPoint System targets moderate-to-severe Rheumatoid Arthritis by stimulating the vagus nerve. This significant investment fue... |
| 12.08.2025 | Top Startup and Tech Funding News – August 12, 2025 | It’s Tuesday, August 12, 2025, and we’re back with a packed edition spotlighting 15 startup and tech funding stories from the U.S. and around the globe. From AI-powered freight management to breakthrough neurotherapies and rare earth magnet... |
| 12.08.2025 | SetPoint Medical: $140 Million Raised To Develop Therapies For Chronic Autoimmune Diseases | SetPoint Medical, focused on therapies for chronic autoimmune diseases, raised $140 million in private funding—$25 million from its Series C and $115 million from its Series D rounds, co-led by Elevage Medical Technologies and Ally Bridge G... |
| 11.08.2025 | SetPoint Medical Raises $140M in Private Financing | SetPoint Medical, a Valencia, CA-based company developing therapies for people living with chronic autoimmune diseases, raised $140M in private financing.
The amount included $25M in the second tranche of its Series C financing, as well as ... |
| 11.08.2025 | SetPoint serves up $140M fundraising after FDA approves its implant for rheumatoid arthritis | Shortly after obtaining a green light from the FDA, SetPoint Medical announced $140 million in new funding to juice the commercialization of its neuromodulation implant for rheumatoid arthritis.
The company described the proceeds as $25 mil... |
| 11.08.2025 | Top Startup and Tech Funding News – August 11, 2025 | It’s Monday, August 11, 2025 — and we’re back with a fresh round of startup and tech funding news updates from across the globe. Today’s capital flow spans high-stakes biotech launches, multi-billion-dollar fintech financing, and ambitious ... |
| 11.08.2025 | SetPoint Medical Raises $140M to Support Commercialization of Rheumatoid Arthritis Therapy | What You Should Know:
– SetPoint Medical, a company focused on developing innovative therapies for chronic autoimmune diseases secures $140M in private financing. This includes the final $25M tranche of its Series C funding and a substantia... |
| 01.11.2023 | Runway Growth Capital Named in Inc.’s 2023 List of Founder-Friendly Investors | Menlo Park, California – November 1, 2023 – Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture-backed companies seeking an alternative to raising equity, announced today that Inc. Magazi... |
| 20.01.2023 | SetPoint Medical Announces Expanded $65M Credit Facility | Valencia, Calif. – January 18, 2022 – SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, today announced a senior secured term loan facility of up to $65 million from Runway Growth ... |
| 19.01.2023 | SetPoint Medical Raises $80M to Advance Platform for Autoimmune Diseases | What You Should Know: |
| 19.01.2023 |
SetPoint Medical raises $80M for nerve stimulation tech that treats autoimmune disease | [Image from the SetPoint Medical website]Autoimmune disease treatment developer SetPoint Medical announced today that it raised $80 million in a preferred stock financing.
Valencia, California–based SetPoint Medical develops a novel platfor... |
| 19.01.2023 | SetPoint Medical Raises $80M in Funding | SetPoint Medical, a Valencia, CA-based clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, raised $80M in funding.
The round was led by Norwest Venture Partners and Viking Global Investors with particip... |
| 13.07.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical | |
| 13.07.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical | WOODSIDE, Calif., July 13, 2021 – Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a senior secu... |
| 13.07.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical | WOODSIDE, Calif., July 13, 2021 /PRNewswire/ -- Runway Growth Capital LLC ("Runway"), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced th... |
| 04.02.2021 | SetPoint Medical Corporation announced that it has received $64.407963 million in funding from a group of investors | On February 4, 2021, SetPoint Medical Corporation closed the transaction. The company has issued 407,963 series B preferred stock for gross proceeds of $407,963 in its third and final tranche bringing total funding raised in the transaction... |
| 21.05.2018 | NEA-backed SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing | SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing. Mr. Sh... |
| 21.05.2018 | Boston Scientific-backed SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing | SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing. Mr. Sh... |
| 21.05.2018 | SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing | SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing. Mr. Sh... |
| 28.08.2017 | SetPoint Medical Raises $30M in Series D Financing | SetPoint Medical, a Valencia, CA-based clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, secured $30m in Series D equity financing.
Backers included existing investors New Ent... |
| 28.08.2017 | Term Sheet — Monday, August 28 | DAY 1
Hi, I’m Polina Marinova, and it’s nice to formally meet you all. Although technically, we already know each other — for the past few months, I’ve been doing the deals section of Term Sheet. Literally started from the bottom (of this n... |
| 28.08.2017 |
SetPoint Medical Raises $30M
| Valencia-based SetPoint Medical, which develops bioelectronic therapy to treat chronic inflammatory diseases, said today that it has raised $30M in its Series D funding. The funding came from existing investors, including NEA, Morgenthaler,... |
| 31.07.2017 | Boston Scientific-backed SetPoint Medical Appoints Terry Bevirt as Clinical Affairs VP | VALENCIA, Calif.–(BUSINESS WIRE)–SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Terry Bevirt as Vice President of Cli... |
| 31.07.2017 | NEA-backed SetPoint Medical Appoints Terry Bevirt as Clinical Affairs VP | VALENCIA, Calif.–(BUSINESS WIRE)–SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Terry Bevirt as Vice President of Cli... |
| 31.07.2017 | Topspin-backed SetPoint Medical Appoints Terry Bevirt as Clinical Affairs VP | VALENCIA, Calif.–(BUSINESS WIRE)–SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Terry Bevirt as Vice President of Cli... |
| 21.03.2017 | Term Sheet — Tuesday, March 21 | OPEN MIC
It’s feedback time!
Paid Content Securing the enterprise without boundaries From ExtraHop
Gustav writes: Would it be possible to take a different view and instead focus at how many workers that directly and indirectly were employed... |
| 20.03.2017 |
SetPoint Medical Adds New Enterprise Associates As Investor
| Valencia-based biomed startup SetPoint Medical announced this morning that it has received a new investment from New Enterprise Associates. Size of the investment, and details of the round, were not announced by the company. SetPoint said t... |
| 20.03.2017 | SetPoint Medical Raises Funding from NEA | SetPoint Medical, a biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced that global venture capital firm New Enterprise Associates, Inc. (NEA) has joined the syndicate of SetPoint Me... |
| 20.03.2017 | SetPoint Medical Receives Investment from NEA | SetPoint Medical, a Valencia, California-based biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, received an investment from venture capital firm New Enterprise Associates, Inc. (NEA).
NEA h... |
| 08.09.2015 |
SetPoint Medical Raises $15M
| Valencia, California-based SetPoint Medical, which is developing medical devices for treating inflammatory diseases, said this morning that it has raised $15M in a Series C1 funding round. The funding came from an un-named, sstrategic inves... |
| 08.09.2015 | SetPoint Medical Grabs $15M |
VALENCIA, CA, SetPoint Medical, a biomedical technology company developing a bioelectronic therapy for inflammatory diseases, announced today that it has secured $15 million in an extension to its Series C equity financing.
>> Clic... |
| 08.09.2015 | Daily funding roundup - September 8, 2015 | Smile Telecoms Holdings bagged $365M; BlaBlaCar secured $160M; SetPoint Medical raised $43M
YouthKiAwaaz, an online news and views platform, has raised angel funding of Rs 4 crore ($600,000) from Quintillion Media, the cross-platform digita... |
| 08.09.2015 | SetPoint Medical Secures $15M in Series C1 Equity Financing | SetPoint Medical, a Valencia, Ca.-based biomedical technology company developing a bioelectronic therapy for inflammatory diseases, secured $15m in Series C1 equity financing.
Backers included the addition of a new strategic investor, along... |
| 04.06.2015 | Neuromodulation: 5 cutting-edge startups deploying this tech | Some of the longest-running work in neuromodulation is being done at the medical device giants – Medtronic, for instance, has had a long-standing neuromodulation program. Boston Scientific and St. Jude Medical are also top contenders.
But s... |
| 08.08.2013 | SetPoint Medical Secures $27M Financing |
VALENCIA, CA, Biomedical technology company developing neuromodulation therapies for inflammatory diseases, announced today that it has secured $27 million in financing from its current investors.
>> Click here for more funding dat... |
| 08.08.2013 | GSK launches $50M fund to invest in pioneering bioelectronics technology | It is looking to invest in three different sets of companies:
New start-up companies that aim to pursue the vision of bioelectronic medicines.
Existing companies with technologies that are interacting with the peripheral nervous system thro... |
| 08.08.2013 |
SetPoint Medical Raises $27.0M
| Valencia-based SetPoint Medical, a developer of biomedical products for treating inflammatory disease, announced today that it has raised $27M in a financing round. The new funding came from Covidien Ventures, Action Potential Venture Capit... |
| 08.08.2013 | SetPoint Medical Secures $27M in Financing | SetPoint Medical, a Valencia, Ca.-based biomedical technology company developing neuromodulation therapies for inflammatory diseases, secured $27m in financing.
Backers included Morgenthaler Ventures, Foundation Medical Partners, Topspin Pa... |
| - | SetPoint Medical | “SetPoint Medical is pioneering bioelectronic medicine to develop a safe and cost-effective approach for treatment of chronic autoimmune diseases.” |
| - | SetPoint Medical | “Regulatinginflammation – THROUGH THE NERVOUS SYSTEM. SetPoint Medical is transforming the treatment of chronic autoimmune conditions to offer patients and providers a potentially safe and cost-effective treatment approach. GROUNDBREAKING S... |
| - | Neuromodulation: 5 cutting-edge startups deploying this tech | Neuromodulation has been around a long time, but in recent years it’s picking up steam as a haute, beyond-the-pill technology.
The concept of neuromodulation is quite simple: It’s an emerging branch of medicine that treats the nervous syste... |
| - | SetPoint Medical | “SetPoint Medical – Start Activating” |
| - | GSK launches $50M fund to invest in pioneering bioelectronics technology | Updated About one year ago GlaxoSmithKline (NYSE: GSK) set up a division to study the electrical impulses along the peripheral nervous system and develop technologies to read, change, or manipulate these impulses to treat acute and chronic ... |
